Cancer drug removed from U.S. market
Monday, June 21, 2010 - 15:03
in Health & Medicine
WASHINGTON, June 21 (UPI) -- Pfizer Inc. announced Monday it is withdrawing its cancer drug Mylotarg for use by U.S. patients with acute myeloid leukemia -- a bone marrow cancer.